Morgan Innovation awarded Queen’s award

In recognition of its contribution to international sales  in the UK.

During the past three years Morgan has increased its overseas earnings by 84 per cent and its exports now account for 85 per cent of its annual sales.

The company’s principal product line is a range of radio frequency lesion generators for bringing pain relief to hospital patients – especially those with acute back problems which it designs and manufactures for Neurotherm Inc. The Company’s strategic partnership with Neurotherm is an important element of its success.

Managing Director Sue Clarke believes the company is also gaining a vital competitive edge by developing and manufacturing a host of new ideas, in fields as diverse as motor neurone disease, stroke treatment and sleep apnoea.

“Working closely with users of specialised equipment in hospitals and clinics we are geared up to identify and develop innovative new ideas for treatment, which might otherwise have gone by the board, because the potential volumes are not sufficiently attractive for large manufacturers,” she says.

A key source of many of the innovative ideas that Morgan develop and put into production is via excellent contacts in the UK research community, particularly universities and hospitals. This is leading to revolutionary new machines for the specialised medical treatments that the company is now working on and, which will become available over the next few years.

Morgan owes a lot of credit for its break-through technologies to Technical Director Howard Clarke, who with wife Sue established the company back in 1987 to develop his pain relief ideas. In growing the company to its present position they have been aided by the financial expertise of fellow director Andrew Rowland.

The Company employs 24 people and, to accommodate its expanding business, moved from Liss to its present new hi-tech premises on Petersfield Business Park in January this year.